Biotech firm Nkure raises seed round

Nkure Therapeutics, a Bengaluru-based biotech company, has raised a seed round, with participation from Endiya Partners, Kotak Investment Advisors, Featherlite, and angel investors. The firm expects to use the investments to complete its manufacturing protocols and complete its preclinical studies. Founded in 2022 by scientist Mahendra Rao (previously Founding Director of the Centre for Regenerative Medicine at the NIH, USA), Nkure has successfully developed an "NK cell" platform at a laboratory scale coupled with agreements with CDMOs in India and the US. It has also secured exclusive licenses to a specialised CAR and related technologies to enable allogeneic cell therapy, the first of its kind in India.